
Ongliza Tablet 5 mg (Saxagliptin Hydrate)
5.29mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.
Saxagliptin hydrate is an ingredient used for the treatment of type 2 diabetes that helps in blood sugar control.
MFDS ingredient code M251489
Saxagliptin hydrate is an ingredient belonging to the DPP-4 inhibitor class of diabetes medications. This ingredient is used in pharmaceuticals to promote insulin secretion and lower blood sugar levels.
Saxagliptin hydrate inhibits the DPP-4 enzyme in the body, preventing the breakdown of incretin hormones. As a result, insulin secretion increases, and blood sugar is effectively regulated.
Approved uses differ by product. Check each product's information for its actual use.
Compared to other DPP-4 inhibitors, saxagliptin hydrate has a long half-life, allowing for once-daily dosing, and provides stable blood sugar control.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
5 total

5.29mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

2.64mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

5.29mg
Tablet · Prescription medication · Combination
AstraZeneca Korea Co., Ltd.

5.29mg
Tablet · Prescription medication · Combination
AstraZeneca Korea Co., Ltd.

5.29mg
Tablet · Prescription medication · Combination
AstraZeneca Korea Co., Ltd.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
Ingredients used together with this ingredient in combination products.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.